Exact Sciences to Sell 4M Shares
Exact Sciences today announced it will sell 4 million shares of its common stock at $25.75 per share until Friday. According to a release, the company intends to use the…
Tag Archives: Exact Sciences
Cologuard Wins Popular Science Award
Exact Sciences announced this week that its Cologuard has won Popular Science magazine’s “Best of What’s New” Award. “Exact Sciences is honored to receive this recognition from the editors of…
Exact Sciences CEO Praises Wisconsin
Wisconsin is a competitive advantage. That was the key message Exact Sciences CEO, President and Chairman Kevin Conroy relayed to attendees during his keynote presentation at the annual Wisconsin Early…
Meriter Now Offering Cologuard
In a span of a month, Exact Sciences has earned backing from organizations such as the Mayo Clinic and Group Health Cooperative for its Cologuard, and now Meriter-UnityPoint Health this…
Cologuard Now Available by Prescription
Physicians networking MDVIP announced this week that Exact Sciences‘ Cologuard is now available by prescription in its system. “MDVIP’s adoption of Cologuard marks an important step for Exact Sciences in allowing a…
Exact Sciences Earns Medicare Coverage
Exact Sciences announced Thursday that Cologuard, the first FDA-approved non-invasive screening test for colorectal cancer and precancer, will be covered by The Centers for Medicare & Medicaid Services (CMS). “We are…
GHC First to Cover Exact Sciences’ Cologuard
Exact Sciences‘ Cologuard, which received its FDA approval last month, will be offered to Group Health Cooperative patients, the organization announced recently. GHC will be the first health plan in Wisconsin to…
Exact Sciences’ Cologuard Gets FDA Nod
A major milestone for Exact Sciences was achieved Monday, when the company announced its colorectal cancer screening test called Cologuard received approval from the U.S. Food and Drug Administration (FDA). “The FDA…
Gov. Doyle Joins Exact Sciences Board
Former Wisconsin Gov. Jim Doyle was elected to the Exact Sciences board of directors, the company announced recently. Doyle, who currently works with both Foley & Lardner and his own company,…
Test for Colorectal Cancer Improves
A preliminary examination of Exact Sciences‘ Cologuard colorectal cancer screening test showed promising data for detection of colorectal cancer and pre-cancerous polyps, the company announced recently. “There is a significant unmet clinical…
